Published online before print May 18, 2007

This Article Full Text Full Text (PDF) All Versions of this Article: ajpath.2007.060828v1 171/1/274    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hosono, K. Articles by Ishiguro, N. Search for Related Content PubMed Articles by Hosono, K. Articles by Ishiguro, N.

(American Journal of Pathology. 2007;171:274-286.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.060828

Hyaluronan Oligosaccharides Inhibit Tumorigenicity of Osteosarcoma Cell Lines MG-63 and LM-8 in Vitro and in Vivo via Perturbation of Hyaluronan-Rich Pericellular Matrix of the Cells

Kozo Hosono^*, Yoshihiro Nishida^*, Warren Knudson, Cheryl B. Knudson, Takahiro Naruse^*, Yoshitaka Suzuki^* and Naoki Ishiguro^*

From the Department of Orthopaedic Surgery,^* Nagoya University Graduate School and School of Medicine, Showa-ku, Nagoya, Japan; and the Department of Anatomy and Cell Biology, Brody School of Medicine, East Carolina University, Greenville, North Carolina

Numerous studies have demonstrated a correlation between hyaluronan expression and the malignant properties of various kinds of cancer, and inhibition of hyaluronan production causes decreased tumor growth. Hyaluronan oligosaccharides have been shown to inhibit several tumor cell types via disruption of receptor-hyaluronan interaction. However, few studies have addressed hyaluronan with respect to osteosarcoma. In this study, we examined the effects of exogenously added hyaluronan oligosaccharides on tumorigenicity of murine osteosarcoma cells, LM-8, and human osteoblastic osteosarcoma cells, MG-63. Moreover, the critical size of oligomers needed to inhibit malignant properties was defined. Fluorescent hyaluronan oligosaccharides accumulated both on the surface of cells and in the cytoplasm, and this retention was blocked by pretreatment with an anti-CD44 monoclonal antibody. Hyaluronan octasaccharides significantly inhibited cell viability and induced apoptosis as defined by cell proliferation and terminal deoxynucleotidyl transferase dUTP nick-end labeling assays, respectively. Octasaccharides also abrogated functional cell-associated matrices and significantly reduced the retention of endogenous hyaluronan. Further, octasaccharide treatment affected an inhibition of cell motility as well as cell invasiveness. Pretreatment of the cells with anti-CD44 antibody reduced the antitumor effect of the octasaccharides. In vivo, intratumoral injection of hyaluronan octasaccharides reduced the hyaluronan accumulation in local tumors, resulting in significant suppression of the formation of distant lung metastasis. Together these data suggest that hyaluronan oligosaccharides have potent antitumor effects functioning in part by the abrogation of hyaluronan-rich cell-associated matrices.

This article has been cited by other articles:

				V. Grishko, M. Xu, R. Ho, A. Mates, S. Watson, J. T. Kim, G. L. Wilson, and A. W. Pearsall IV Effects of Hyaluronic Acid on Mitochondrial Function and Mitochondria-driven Apoptosis following Oxidative Stress in Human Chondrocytes J. Biol. Chem., April 3, 2009; 284(14): 9132 - 9139. [Abstract] [Full Text] [PDF]

				T. Kaneiwa, S. Yamada, S. Mizumoto, A. M. Montano, S. Mitani, and K. Sugahara Identification of a Novel Chondroitin Hydrolase in Caenorhabditis elegans J. Biol. Chem., May 30, 2008; 283(22): 14971 - 14979. [Abstract] [Full Text] [PDF]